Ceremorphic
Ceremorphic is a company that develops high-performance AI training supercomputing and offers proprietary architectures for in silico drug design, holding over 200 patents and utilizing 3nm process technology.
Services
Ceremorphic offers a comprehensive range of services centered around their proprietary architecture aimed at high-performance AI training and in silico drug design. Their innovative solutions extend to quantum-resistant security that ensures data protection in various applications. The company's technology supports sectors including data centers, life sciences, automotive, robotics, and metaverse processing.
Proprietary Technology and Architecture
Ceremorphic has developed a proprietary multi-thread processing architecture named ThreadArch. This architecture is designed from the ground up to facilitate high-performance AI training supercomputing. Additionally, it utilizes cutting-edge 3nm process technology, enhancing computing efficiency and performance across various applications. The company's architecture also supports a broad range of markets, ensuring versatile applicability and robust performance.
Patents
Ceremorphic holds over 200 patents, underscoring its commitment to innovation and protecting its proprietary technologies. These patents cover various aspects of the company's architecture and technological advancements in high-performance computing and AI, in silico drug design, and quantum-resistant security solutions.
Industry Recognition and Awards
In 2023, Ceremorphic was recognized for its promising contributions to the tech industry by being named to the EE Times Silicon 100 List of the Most Promising Start-Ups. Additionally, the company won the Start-Up of the Year award from Electronics Maker, highlighting its innovative achievements and potential in transforming multiple sectors.